Joanne M. Donovan
CIK 1644087 · CMO · last filed 2026-05-05
Joanne M. Donovan is a CMO who has filed 24 SEC Form 4 insider transactions across 2 companies since 2015. The most recent filing, for EWTX, was dated May 5, 2026. Across all open-market trades the lifetime net is −$4.6M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $152.1K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$152.1K
2
24
-$4.64M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EWTX | CMO | 4,367 | $34.83 | $152.1K | -$4.64M | 15 | 2026-05-05 |
| Astria Therapeutics, Inc. (CATB) Delisted | CMO; SVP Clinical Development | 409 | $8.54 | $3.5K | $0 | 9 | 2020-02-14 |
Recent Filings
24 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-05 | EWTX | Mixed | −5,230 | -$1.74M | EDGAR |
| 2026-04-02 | EWTX | Mixed | — | -$723.2K | EDGAR |
| 2026-03-30 | EWTX | Sell (S) | −16,358 | -$506.7K | EDGAR |
| 2025-08-14 | EWTX | Mixed | +2,919 | -$38.3K | EDGAR |
| 2025-05-07 | EWTX | Mixed | +5,230 | -$85.3K | EDGAR |
| 2025-01-30 | EWTX | Mixed | — | -$513.7K | EDGAR |
| 2024-09-24 | EWTX | Sell (S) | −7,162 | -$202.6K | EDGAR |
| 2024-08-14 | EWTX | Grant (A) | — | $0 | EDGAR |
| 2024-05-03 | EWTX | Mixed | +6,735 | -$69.6K | EDGAR |
| 2023-08-18 | EWTX | Grant (A) | — | $0 | EDGAR |